Status
Conditions
Treatments
About
This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
Full description
The goal of this clinical trial is to test the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control function in students with and without attention-related difficulties. The main questions it aims to answer are (1) does NeuroTrainer improve attentional and executive control function, (2) does NeuroTrainer engage the target of ADHD inattention symptoms by identifying the target and demonstrating proximal changes in it, and (3) does NeuroTrainer demonstrate transfer of skill with improvement in academic behaviors. Researchers will compare students who use NeuroTrainer to a control condition to see if the NeuroTrainer intervention produces significant improvements.
Participants in the intervention group will engage in virtual reality (VR) sessions which include physical activity and cognitive training. Cognitive training will maximize time at performance thresholds and optimize for variability in task dynamics and demands.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
155 participants in 2 patient groups
There are currently no registered sites for this trial.
Central trial contact
Jeff Nyquist, Ph.D.; Julie Schweitzer, Ph.D.
Start date
Sep 01, 2024 • 8 months ago
Today
May 04, 2025
End date
Feb 28, 2026 • in 9 months
Lead Sponsor
Collaborating Sponsors
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal